0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          p73 is expressed as multiple C-terminal isoforms, but their expression and activity are largely unknown. Here, we identified p73α1 as a p73 C-terminal isoform that results from exon 12 ( E12) exclusion. We showed that E12 deficiency in mice leads to systemic inflammation but not spontaneous tumors. We also showed that Notch1 is regulated by p73α1 and plays a critical role in p73-dependent tumor suppression and systemic inflammation.

          Abstract

          p73, a p53 family member, undergoes alternative splicing at the 3′ end to produce multiple isoforms, but their expression and activity are largely unknown. Thus, CRISPR was used to knock out exon 12 ( E12) in human cancer cell lines and mice, leading to isoform switch from p73α to isoform p73α1. We found that p73α1 is naturally expressed and induced by DNA damage. We also found that knockout of E12 suppresses cell growth and migration in H1299 and MIA PaCa-2 cells and promotes cellular senescence in mouse embryonic fibroblasts. Similarly, ectopic expression of p73α1 suppresses cell proliferation, whereas knockdown of p73α1 restores the cell proliferative and migratory capacities of E12 −/− cells. Consistently, we found that E12 +/− mice are not prone to spontaneous tumors. Instead, E12 +/− mice are prone to systemic inflammation and exhibit elevated TNFα expression in inflamed tissues. Moreover, we found that Notch1, a master regulator of the inflammatory response, is regulated by p73α1 and highly expressed in E12 −/− cells and inflamed E12 +/− mouse tissues. Furthermore, through knockdown of p73α1 and/or Notch1 in E12 −/− cells, we found that Notch1 is necessary for p73α1-mediated growth suppression. Together, these data suggest that p73α1 plays a critical role in tumor suppression and the inflammatory response via Notch1.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: found
          • Article: not found

          Genome engineering using the CRISPR-Cas9 system.

          Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1-2 weeks, and modified clonal cell lines can be derived within 2-3 weeks.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            NF-κB: a key role in inflammatory diseases

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

              Normal somatic cells invariably enter a state of irreversibly arrested growth and altered function after a finite number of divisions. This process, termed replicative senescence, is thought to be a tumor-suppressive mechanism and an underlying cause of aging. There is ample evidence that escape from senescence, or immortality, is important for malignant transformation. By contrast, the role of replicative senescence in organismic aging is controversial. Studies on cells cultured from donors of different ages, genetic backgrounds, or species suggest that senescence occurs in vivo and that organismic lifespan and cell replicative lifespan are under common genetic control. However, senescent cells cannot be distinguished from quiescent or terminally differentiated cells in tissues. Thus, evidence that senescent cells exist and accumulate with age in vivo is lacking. We show that several human cells express a beta-galactosidase, histochemically detectable at pH 6, upon senescence in culture. This marker was expressed by senescent, but not presenescent, fibroblasts and keratinocytes but was absent from quiescent fibroblasts and terminally differentiated keratinocytes. It was also absent from immortal cells but was induced by genetic manipulations that reversed immortality. In skin samples from human donors of different age, there was an age-dependent increase in this marker in dermal fibroblasts and epidermal keratinocytes. This marker provides in situ evidence that senescent cells may exist and accumulate with age in vivo.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc Natl Acad Sci U S A
                pnas
                pnas
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                26 May 2022
                31 May 2022
                26 November 2022
                : 119
                : 22
                : e2123202119
                Affiliations
                [1] aComparative Oncology Laboratory, Schools of Medicine and Veterinary Medicine, University of California , Davis, CA 95616;
                [2] bDepartment of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390
                Author notes
                2To whom correspondence may be addressed. Email: xbchen@ 123456ucdavis.edu or jinzhang@ 123456ucdavis.edu .

                Edited by Carol Prives, Columbia University, New York, NY; received December 22, 2021; accepted April 11, 2022

                Author contributions: K.N.L., J.Z., and X.C. designed research; K.N.L., W.Y., X.K., W.S., and J.Z. performed research; K.N.L., M.C., J.Z., and X.C. analyzed data; and K.N.L., J.Z., and X.C. wrote the paper.

                1Present address: Berkeley Regional Lab, Pathology/Lab-Histology Department, The Permanente Medical Group Inc., Berkeley, CA 94710.

                Author information
                https://orcid.org/0000-0001-6754-0480
                Article
                202123202
                10.1073/pnas.2123202119
                9296871
                35617425
                14289657-aae2-4737-8d9f-d1665eef30d0
                Copyright © 2022 the Author(s). Published by PNAS.

                This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                : 11 April 2022
                Page count
                Pages: 11
                Funding
                Funded by: HHS | NIH | Office of Extramural Research, National Institutes of Health (OER) 100006955
                Award ID: CA081237
                Award Recipient : Xinbin Chen
                Funded by: HHS | NIH | Office of Extramural Research, National Institutes of Health (OER) 100006955
                Award ID: CA224433
                Award Recipient : Xinbin Chen
                Funded by: Tobacco-Related Disease Research Program (TRDRP) 100005188
                Award ID: T31IP1727
                Award Recipient : Jin Zhang
                Funded by: HHS | NIH | National Cancer Institute (NCI) 100000054
                Award ID: CA093373
                Award Recipient : Xinbin Chen
                Funded by: UC | University of California, Davis (UCD) 100007707
                Award ID: HL007013
                Award Recipient : Kyra Nicole Laubach
                Categories
                409
                Biological Sciences
                Cell Biology

                p53 family,p73,p73 c-terminal isoforms,notch1 pathway,tumor suppressor

                Comments

                Comment on this article